Vectobac 12 AS

Primær information

Handelsnavn:
Vectobac 12 AS Flydende middel

Aktiv bestanddel:
H14

Tilgængelig fra:
Cillus A/S

INN (International Name):
H14

Lægemiddelform:
Flydende middel

Sammensætning:
1200 ITU/mg Bacilus thuringiensis var. H14

Brugt til:
Planter

Medicin typen:
agrokemiske

Dokumenter

for sundhedspersonale:
Produktresumé

for den brede offentlighed:
Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

Anmode informationsbrochure for offentligheden.

Lokation

Fås i:
Danmark

Sprog:
dansk

Andre oplysninger

Status

Kilde:
SEGES Landbrug & Fødevarer

Autorisation status:
Udgået

Autorisationsnummer:
Ingen afstandskrav.

Sidste ændring:
23-07-2018

Produktresumé: dosering, interaktioner, bivirkninger

LEVERANDØRBRUGSANVISNING

(Sikkerhedsdatablad)

Udarbejdet efter Arbejdsministeriets bekendtgørelse nr 485 af 16. juni 1995 om stoffer og materialer, § 16, stk. 2.

VECTOBAC

12AS

1. Produktidentifikation

VECTOBAC

12AS

Produkttype:

Biologisk insektmiddel til bekæmpelse

af larver på planter

Leverandør:

Cillus A/S

Tlf.: 4491 6055

Kobbervej 8

Fax.: 4491 6575

2730

Herlev

Kontaktperson: E. Rubæk

2. Oplysning om indholdsstoffer:

Analyse:

VECTOBAC

12AS indeholder 1200

International Toxic Units pr. mg

(1,25%) af Bacillus thuringiensis H-14.

Resten inaktive fyldstoffer (98,75%).

3. Faredeklaration

For mennesker: Undgå kontakt med huden og øjnene.

4. Førstehjælp

Øjne:

Kommer stoffet i øjnene, skylles straks

med vand og læge kontaktes.

Hud:

Forurenet tøj fjernes straks, og forure-

net hud vaskes straks med vand og

sæbe.

Indånding:

Søg frisk luft og hvile

Indtagelse:

Skyl munden, drik rigeligt vand og søg

læge.

Forbrænding:

Ikke brændbart.

5. Forholdsregler ved brand

Produktet bør så vidt muligt fjernes fra brandstedet.

Sluk med pulver, skum eller vandtåge. Hold emballa-

gerne afkølet ved oversprøjtning med vand, hvis udsat

for stærk varme. Undgå indånding af røg og gasser, der

udvikles ved branden.

6. Forholdsregler ved spild

Må ikke hældes i afløb, vandløb eller på jorden.

Evt. spild opsamles med væskeabsorberende materiale,

og dette skal sammen med tom emballage og rester af-

leveres til den kommunale modtageordning.

7. Håndtering og opbevaring

Undgå spild. Brug ansigtsskærm eller beskyttelsesbril-

ler, handsker og forklæde ved udsprøjtning.

S2 -Opbevares utilgængeligt for børn.

S13 -Må ikke opbevares sammen med fødevarer, drik-

kevarer og foderstoffer.

8. Eksponeringskontrol/Personlige værnemidler

Undgå indånding af sprøjtetågen

Undgå kontakt med huden

Brug beskyttelseshandsker. Flerlagshandsker bør fore-

trækkes. Tilsmudset tøj skiftes straks.

Vask huden efter arbejdet.

Efter sprøjtning skal planterne være tørre på bladene,

inden håndtering påbegyndes.

Følg i øvrigt Arbejdstilsynets vejledning og regler om

arbejdstøj og personlige værnemidler.

9. Fysisk-kemiske egenskaber

Tilstandsform:

Vandig suspension

Farve:

Lysebrun

Lugt:

Fermenteringsagtig

Kogepunkt:

Frysepunkt:

Flammepunkt:

ikke brændbart

Opløselighed

i vand:

Opslemning

Vægtfylde:

1,05

ca. 5

10. Stabilitet og reaktivitet

Produktet er lagerfast i mindst 2 år i uåbnet emballage.

Undgå store temperaturudsving. Undgå direkte sollys.

11. Toksikologiske oplysninger

Akut LD-50:

Ved indtagelse > 5000 mg/kg

Ved hudkontakt > 5000 mg/kg

Akut LC-50:

Ved inhalering >5,34 mg/l

Indånding:

Kan give svag irritation.

Hudkontakt:

Kan give svag irritation ved langvarig

påvirkning.

Øjnene:

Stænk i øjnene giver svag irritation

(sviden)

VECTOBAC

12AS

29.04.04

Side 2 af 2

12. Miljøoplysninger

Såvel B.t. som fyldstofferne anses for ikke særlig ska-

delig for miljøet. Se i øvrigt punkt 6.

13. Bortskaffelse

Tom emballage må ikke genanvendes til andet formål.

Tom emballage og rester afleveres til den kommunale

modtageordning.

Rengjort emballage afleveres som dagrenovation.

14. Transportoplysninger

VECTOBAC

12AS er ikke underlagt ADR, hvorfor

der ikke er specielle regler for tranport.

15. Forholdsregler ved brug:

Opbevaring:

VECTOBAC

12AS opbevares frost-

frit.

Må ikke stå i direkte sollys.

Holdbar i uåbnet emballage i mindst 2

år.

Emballagen omrystes grundigt inden det afmålte

kvantum hældes i sprøjtebeholderen under moderat

omrøring.

Tømt og skyllet emballage bortskaffes med dagre-

novationen.

Kommer væsken i øjnene, skyl da omgående med

rigeligt vand

Undgå indånding af sprøjtevæsken.

Anvend ansigtsskærm, handsker og forklæde ved

udsprøjtning.

Planterne skal være tørre inden håndtering påbe-

gyndes.

Vask sprøjteudstyret straks efter arbejdets ophør.

Der kræves ingen særlig uddannelse, dog må unge

under 18 år ikke arbejde med produktet.

16. Brugsanvisning

VECTOBAC

12AS er et biologisk bekæmpelses-

middel, der anvendes mod larver af sørgemyg

(svampemyg) i væksthuse, samt filterfluer (møg-

fluer) i rensningsanlæg og stankelbenlarver på

græsarealer.

VECTOBAC

12AS anvendes erhvervsmæssigt

eller privat efter behov.

Der er ingen behandlingsfrist. Vask hænder og ud-

styr efter endt udsprøjtning.

VECTOBAC

12AS sprøjtevandes på borde, i

potter og på jorden under bordene. Der vandes så

de øverste 3-4 cm af voksemediet er gennemvædet

-ca 2 ltr. væske pr m

. Gennemvanding bør have

fundet sted, inden sprøjtevanding -ikke omvendt.

VECTOBAC

12AS optages af sørgemyggens

larver i jorden. Efter 1-2 dages forløb standser lar-

verne fødeoptagelsen og dør.

Doseringen er 0,125 - 0,25% styrke i 2 ltr. vand pr.

. Svarende til, at der anvendes 2½ - 5 ml

VECTOBAC

12AS pr m

. 1 ltr. VECTOBAC

12AS rækker således til 200 - 400 m

behandlet

areal.

Første behandling umiddelbart efter oppotning.

Behandlingen gentages med 5 - 7 dages interval, i

alt 3 gange. Brug gule limplader til at kontrollere

om flyvningen er holdt op. VECTOBAC

12AS

kan sprøjtevandes sammen med nematoder.

VECTOBAC

12AS må ikke blandes med gød-

ning eller lign., der kan neutralisere virkningen -

hverken ved tankblanding eller drypvanding.

Tålsomhed:

Mange plantearter har været prøvet

uden skade, når doseringen overholdes.

Når der skiftes fra en art/sort til en an-

den, eller kulturbetingelserne ændres,

anbefales det at prøve få planter, inden

et helt parti behandles.

VECTOBAC

12AS er anerkendt af

Danmarks Jordbrugsforskning til be-

handling mod larver af sørgemyg på

prydplanter i væksthus med 5 ml pr m

Larver af mosestankelben på græsarealer kan være et

problem. Især hvis der året efter skal sås andre afgrø-

der. En total bekæmpelse af mosestankelben er ikke

mulig, men en væsentlig reduktion af larvebestanden

kan forventes.

Tidspunkt:

I oktober måned vælges en mild og fugtig dag. Sprøjt

sidst på dagen når larverne kommer op til overfladen

for at æde af planterne.

Dosering:

2 -2½ ltr. VECTOBAC

12AS pr. ha i mindst 400 ltr.

vand, gerne mere. Evt. i let regnvejr.

Genbehandling:

Hvis klækning af larver sker over en lang periode, kan

behandlingen gentages - evt. næste forår, fortsat med

stor fugtighed i jordoverfladen og gerne i let regn.

Læs mere om bekæmpelse af mosestankelben i ”Mar-

kens sygdomme og skadedyr”.

Udarbejdet af E. Rubæk den 29.04.2004

Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

Anmode informationsbrochure for offentligheden.
Dokumenter på andre sprog er tilgængelige her

Adgang til dette dokument er kun tilgængelig for registrerede brugere.

Tilmeld dig nu for fuld adgang

Vectobac 12 AS Flydende middel - dansk - Produktets egenskaber

13-2-2019

Pesticide active substances that do not require a review of the existing maximum residue levels under Article 12 of Regulation (EC) No 396/2005

Published on: Tue, 12 Feb 2019 According to Article 12(1) of Regulation (EC) No 396/2005, EFSA shall provide within 12 months from the date of the inclusion or non‐inclusion of an active substance in Annex I to Directive 91/414/EEC a reasoned opinion on the review of the existing maximum residue levels (MRLs) for that active substance. Among the active substances that need to be reviewed under Article 12(1) of Regulation (EC) No 396/2005, EFSA identified 13 active substances for which a review of MRLs i...

Europe - EFSA - European Food Safety Authority EFSA Journal

11-2-2019

World Waters Issues Voluntary Recall of Select WTRMLN WTR Original 12 Packs Due To The Possible Presence of Soft Plastic Pieces. Company Urges Consumers to Check Packages Prior to Consumption

World Waters, LLC is initiating a voluntary recall of certain lots of Cold Pressed Juice Watermelon WTRMLN WTR Original 12 packs due to the potential presence of soft plastic that may be loosely floating in some of the finished products

FDA - U.S. Food and Drug Administration

5-2-2019

Evaluation of confirmatory data following the Article 12 MRL review for flutolanil

Published on: Mon, 04 Feb 2019 The applicant Nihon Nohyaku Co. Ltd. submitted a request to the competent national authority in Finland to evaluate the confirmatory data that were identified for flutolanil in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The data gaps related to new residue trials for globe artichokes and beans with pods and for storage stability data in products of animal origin were addressed. Further risk mana...

Europe - EFSA - European Food Safety Authority EFSA Journal

5-2-2019

Evaluation of confirmatory data following the Article 12 MRL review for spinosad

Published on: Mon, 04 Feb 2019 The applicant Dow AgroSciences Ltd submitted a request to the competent national authority in the Netherlands to evaluate the confirmatory data that were identified for spinosad in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The data gaps related to residue trials on globe artichokes, flowering brassica and the nature of residues in processed commodities were satisfactorily addressed. A new feedi...

Europe - EFSA - European Food Safety Authority EFSA Journal

2-2-2019

Evaluation of confirmatory data following the Article 12 MRL review for imazamox

Published on: Fri, 01 Feb 2019 The applicant BASF SE submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified for imazamox in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, the applicant submitted new residue trials on rice. Since the number of trials was not sufficient, the data gap was considered only partially addressed. The remaining dat...

Europe - EFSA - European Food Safety Authority EFSA Journal

1-2-2019

Review of the existing maximum residue levels for imidacloprid according to Article 12 of Regulation (EC) No 396/2005

Published on: Thu, 31 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance imidacloprid. To assess the occurrence of imidacloprid residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC, the MRLs established by the Codex Alimentarius Commission as well as the import to...

Europe - EFSA - European Food Safety Authority EFSA Journal

1-2-2019

Review of the existing maximum residue levels for hexythiazox according to Article 12 of Regulation (EC) No 396/2005

Published on: Thu, 31 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance hexythiazox. To assess the occurrence of hexythiazox residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008, the MRLs established by the Codex Alimentarius Commission as well a...

Europe - EFSA - European Food Safety Authority EFSA Journal

30-1-2019

Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee

February 12, 2019: Joint Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee

FDA - U.S. Food and Drug Administration

26-1-2019

Scientific Opinion on Flavouring Group Evaluation 217 Revision 2 (FGE.217Rev2), consideration of genotoxic potential for α,β‐unsaturated ketones and precursors from chemical subgroup 4.1 of FGE.19: lactones

Published on: Fri, 25 Jan 2019 The Panel on Food Additives and Flavourings of the European Food Safety Authority was requested to evaluate the genotoxic potential of 12 flavouring substances from subgroup 4.1 of FGE.19 in the Flavouring Group Evaluation 217 (FGE.217). Based on experimental data, in previous versions of this FGE (FGE.217 and FGE217Rev1), for 6‐methylcoumarin [FL‐no: 13.012] and 5‐ethyl‐3‐hydroxy‐4‐methylfuran‐2(5H)‐one [FL‐no: 10.023] the concern for genotoxicity was ruled out. 6‐Methylc...

Europe - EFSA - European Food Safety Authority EFSA Journal

25-1-2019

Review of the existing maximum residue levels for spiromesifen according to Article 12 of Regulation (EC) No 396/2005

Published on: Wed, 23 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance spiromesifen. To assess the occurrence of spiromesifen residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Regulation (EC) No 1107/2009, the MRLs established by the Codex Alimentarius Commission, as well as the ...

Europe - EFSA - European Food Safety Authority EFSA Journal

23-1-2019

FDA Cautions Pet Owners Not to Feed One Lot of Hare Today Gone Tomorrow Due to <i>Salmonella</i> and <i>Listeria monocytogenes</i>

The FDA is cautioning pet owners not to feed Hare Today Gone Tomorrow Ground Chicken/Bones/Organs, lot 12.04.2018, after the product tested positive for Salmonella and Listeria monocytogenes. If you have this lot of Hare Today Gone Tomorrow Ground Chicken/Bones/Organs, throw it away.

FDA - U.S. Food and Drug Administration

17-1-2019

Safety of cassia gum as a feed additive for cats and dogs based on a dossier submitted by Glycomer GmbH

Published on: Wed, 16 Jan 2019 The additive cassia gum consists mainly of high-molecular weight polysaccharides composed primarily of a linear chain of 1,4-b-D-mannopyranose units with 1,6-linked a-D-galactopyranose units. In 2014, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) delivered an opinion on the safety and efﬁcacy of cassia gum in cats and dogs. The Panel concluded, based on positive ﬁndings observed in a bacterial reverse mutation test with a semi-reﬁned cassia...

Europe - EFSA - European Food Safety Authority EFSA Journal

17-1-2019

Safety and efficacy of 8‐mercapto‐p‐menthan‐3‐one and p‐menth‐1‐ene‐8‐thiol belonging to chemical group 20 when used as flavourings for all animal species

Published on: Wed, 16 Jan 2019 Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of two compounds belonging to chemical group 20 (aliphatic and aromatic mono‐ and di‐thiols and mono‐, di‐, tri‐, and polysulfides with or without additional oxygenated functional groups). 8‐Mercapto‐p‐menthan‐3‐one [12.038] and p‐menth‐1‐ene‐8‐thiol [12.085] are currently ...

Europe - EFSA - European Food Safety Authority EFSA Journal

16-1-2019

Review of the existing maximum residue levels for dazomet according to Article 12 of Regulation (EC) No 396/2005

Published on: Tue, 15 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance dazomet. To assess the occurrence of dazomet residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC as well as the European authorisations reported by Member States (including the supporting re...

Europe - EFSA - European Food Safety Authority EFSA Journal

15-1-2019

Review of the existing maximum residue levels for metam according to Article 12 of Regulation (EC) No 396/2005

Published on: Mon, 14 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance metam. To assess the occurrence of metam residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008C as well as the European authorisations reported by Member States (including the...

Europe - EFSA - European Food Safety Authority EFSA Journal

15-1-2019

Assessment of genetically modified soybean A2704‐12 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐009)

Published on: Mon, 14 Jan 2019 Following the submission of application EFSA‐GMO‐RX‐009 under Regulation (EC) No 1829/2003 from Bayer CropScience N.V., the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the herbicide‐tolerant genetically modified soybean A2704‐12, for food and feed uses, import and processing, excluding cultivation within th...

Europe - EFSA - European Food Safety Authority EFSA Journal

15-1-2019

Review of the existing maximum residue levels for fluometuron according to Article 12 of Regulation (EC) No 396/2005

Published on: Mon, 14 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance fluometuron. To assess the occurrence of fluometuron residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008 as well as the European authorisations reported by Member States (in...

Europe - EFSA - European Food Safety Authority EFSA Journal

9-1-2019

Review of the existing maximum residue levels for sedaxane according to Article 12 of Regulation (EC) No 396/2005

Published on: Tue, 08 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance sedaxane. To assess the occurrence of sedaxane residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011, the MRLs established by the Codex Alimentarius Commission as well as the...

Europe - EFSA - European Food Safety Authority EFSA Journal

9-1-2019

Review of the existing maximum residue levels for triazoxide according to Article 12 of Regulation (EC) No 396/2005

Published on: Tue, 08 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance triazoxide. To assess the occurrence of triazoxide residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008, as well as the European authorisations reported by Member States. Bas...

Europe - EFSA - European Food Safety Authority EFSA Journal

9-1-2019

Review of the existing maximum residue levels for chromafenozide according to Article 12 Regulation (EC) No 396/2005

Published on: Tue, 08 Jan 2019 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance chromafenozide. Considering the information provided by Member States, neither EU uses nor import tolerances are currently authorised for chromafenozide within the EU. Furthermore, no MRLs are established by the Codex Alimentarius Commission (codex maximum residue limits) for this active subst...

Europe - EFSA - European Food Safety Authority EFSA Journal

20-12-2018

Terrific Care, LLC. / Medex Supply Dist, Inc. issues Nationwide Recall of CoaguChek Test Strips

On 12/19/2018, Terrific Care, LLC. / Medex Supply Dist, Inc. initiated a nationwide recall of Roche CoaguChek test strips distributed directly to U.S. consumers by Terrific Care, LLC. / Medex Supply Dist, Inc. The products have been found to inaccurately report high INR test results.

FDA - U.S. Food and Drug Administration

19-12-2018

Wegmans Issues Voluntary Recall of Fresh Cauliflower Rice, Veggie/Cauliflower Rice Blend and Stir-Fry Mix with Cauliflower

Rochester, NY – Wegmans Food Markets, Inc. has issued a voluntary recall of fresh Cauliflower Rice, Veggie Cauliflower Rice Blend and Stir-Fry Mix with Cauliflower, sold in the produce department between 12/7/18 and 12/18/18, because it may be contaminated with Escherichia coli O157:H7 bacteria (E. Coli O157:H7). E. coli O157:H7 causes a diarrheal illness often with bloody stools. Although most healthy adults can recover completely within a week, some people can develop a form of kidney failure called He...

FDA - U.S. Food and Drug Administration

18-12-2018

Apo-Prednisone 5 mg Tablet (2018-12-18)

Health Canada

18-12-2018

Review of the existing maximum residue levels for pencycuron according to Article 12 of Regulation (EC) No 396/2005

Published on: Mon, 17 Dec 2018 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance pencycuron. To assess the occurrence of pencycuron residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008 as well as the European authorisations reported by Member States (incl...

Europe - EFSA - European Food Safety Authority Publications

17-12-2018

Vijf jaar NIX brengt normverandering roken en drinken op gang

Op 1 januari is het precies vijf jaar geleden dat de leeftijdsgrens voor roken en drinken werd verhoogd naar 18 jaar. In deze periode is er veel veranderd, blijkt uit een recente peiling in opdracht van het ministerie van VWS. Zo vindt ongeveer driekwart van de ouders en tieners het ‘normaal’ dat je pas mag roken en drinken vanaf 18 jaar. 78,2% van de ouders vindt dit tegenover 75,4% van de jongeren. De afgelopen jaren is het gebruik van alcohol onder tieners teruggelopen. Sinds 2011 gaat het in de total...

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

17-12-2018

Teva Canada Product Recall (2018-12-17)

Health Canada

14-12-2018

Management Board meeting: 12-13 December 2018, European Medicines Agency, London, UK, from 12/12/2018 to 13/12/2018

Europe - EMA - European Medicines Agency

14-12-2018

European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018

European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, from 03/12/2018 to 03/12/2018

Europe - EMA - European Medicines Agency

13-2-2019

Orphan designation: Recombinant IgG degrading enzyme of Streptococcus pyogenes (imlifidase), Prevention of graft rejection following solid organ transplantation, 12/01/2017, Positive

Europe - EMA - European Medicines Agency

13-2-2019

Orphan designation: Agammaglobulinaemia tyrosine kinase, Treatment of pemphigus, 12/12/2017, Positive

Europe - EMA - European Medicines Agency

13-2-2019

Orphan designation: Humanised single-chain monoclonal antibody against CD37 (otlertuzumab), Treatment chronic lymphocytic leukaemia, 06/12/2012, Positive

Europe - EMA - European Medicines Agency

12-2-2019

Vaxxitek HVT + IBD (Merial)

Vaxxitek HVT + IBD (Active substance: Live vHVT013-69 recombinant virus) - Centralised - Yearly update - Commission Decision (2019)1098 of Tue, 12 Feb 2019

Europe -DG Health and Food Safety

12-2-2019

Halagon (Emdoka bvba)

Halagon (Active substance: halofuginone) - Centralised - Yearly update - Commission Decision (2019)1095 of Tue, 12 Feb 2019

Europe -DG Health and Food Safety

12-2-2019

Helicobacter Test INFAI (INFAI GmbH)

Helicobacter Test INFAI (Active substance: 13C - urea) - Centralised - Yearly update - Commission Decision (2019)1109 of Tue, 12 Feb 2019

Europe -DG Health and Food Safety

12-2-2019

Kriptazen (Virbac)

Kriptazen (Active substance: halofuginone) - Centralised - Authorisation - Commission Decision (2019)1097 of Tue, 12 Feb 2019 European Medicines Agency (EMA) procedure number: EMEA/V/C/4868

Europe -DG Health and Food Safety

12-2-2019

Vectra Felis (Ceva SantE Animale)

Vectra Felis (Active substance: dinotefuran, pyriproxyfen) - Centralised - Renewal - Commission Decision (2019)1096 of Tue, 12 Feb 2019 European Medicines Agency (EMA) procedure number: EMEA/V/C/2746/R/08

Europe -DG Health and Food Safety

5-2-2019

Human medicines European public assessment report (EPAR): Bevespi Aerosphere, glycopyrronium / formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 18/12/2018, Status: Authorised

Human medicines European public assessment report (EPAR): Bevespi Aerosphere, glycopyrronium / formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 18/12/2018, Status: Authorised

Europe - EMA - European Medicines Agency

4-2-2019

Memantine Accord (Accord Healthcare S.L.U.)

Memantine Accord (Active substance: memantine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2019)844 of Mon, 04 Feb 2019 European Medicines Agency (EMA) procedure number: EMEA/H/C/2766/T/12

Europe -DG Health and Food Safety

4-2-2019

EU/3/12/1083 (Voisin Consulting S.A.R.L.)

EU/3/12/1083 (Active substance: Humanised single chain monoclonal antibody against CD37) - Transfer of orphan designation - Commission Decision (2019)814 of Mon, 04 Feb 2019 European Medicines Agency (EMA) procedure number: EMA/OD/0000003624

Europe -DG Health and Food Safety

1-2-2019

Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Myotonic Disorders, Date of authorisation: 18/12/2018, Status: Authorised

Europe - EMA - European Medicines Agency

1-2-2019

EU/3/12/1068 (StEphane Gibaud)

EU/3/12/1068 (Active substance: Melarsoprol) - Transfer of orphan designation - Commission Decision (2019)813 of Fri, 01 Feb 2019 European Medicines Agency (EMA) procedure number: EMA/OD/0000003439

Europe -DG Health and Food Safety

1-2-2019

Withdrawn application: Cavoley, pegfilgrastim, Date of withdrawal: 20/12/2018, Initial authorisation

Europe - EMA - European Medicines Agency

1-2-2019

Withdrawn application: Efgratin, pegfilgrastim, Date of withdrawal: 20/12/2019, Initial authorisation

Europe - EMA - European Medicines Agency

16-1-2019

EU/3/12/1062 (EUSA Pharma (Netherlands) B.V.)

EU/3/12/1062 (Active substance: Chimeric monoclonal antibody against GD2) - Transfer of orphan designation - Commission Decision (2019)238 of Wed, 16 Jan 2019 European Medicines Agency (EMA) procedure number: EMA/OD/0000003198

Europe -DG Health and Food Safety

11-1-2019

Consultation: Good Clinical Practice Inspections Program

The TGA is seeking comments from interested parties on a pilot Good Clinical Practice (GCP) Inspections Program of 12 months duration that will inform a routine GCP Inspections Program. Closing date: 22 February 2019

Therapeutic Goods Administration - Australia

20-12-2018

TGA presentations: CAPSIG Seminar, 12 September 2018

Overview of regulatory requirements introduced as part of PIC/s PE009-13 Guide to GMP and a summary of the new PI041-1 Data Integrity

Therapeutic Goods Administration - Australia

19-12-2018

On 12/12/18 GE Healthcare Recalled CareScape R860 Inspiratory Safety Guard Due to Risk of Disconnection from Breathing Circuit. @US_FDA has identified this as a Class I Recall, the most serious type recall. Read more about the recall: https://go.usa.gov/

On 12/12/18 GE Healthcare Recalled CareScape R860 Inspiratory Safety Guard Due to Risk of Disconnection from Breathing Circuit. @US_FDA has identified this as a Class I Recall, the most serious type recall. Read more about the recall: https://go.usa.gov/xE383 #MedicalDevice #FDA pic.twitter.com/S2EbMdmwpe

FDA - U.S. Food and Drug Administration

19-12-2018

EU/3/12/1087 (Richardson Associates Regulatory Affairs Ltd)

EU/3/12/1087 (Active substance: Recombinant modified human growth hormone) - Transfer of orphan designation - Commission Decision (2018)9014 of Wed, 19 Dec 2018 European Medicines Agency (EMA) procedure number: EMA/OD/0000002652

Europe -DG Health and Food Safety

18-12-2018

Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Dengue, Date of authorisation: 12/12/2018, Status: Authorised

Europe - EMA - European Medicines Agency

18-12-2018

EU/3/12/963 (Helsinn Birex Pharmaceuticals Ltd)

EU/3/12/963 (Active substance: Chlormethine) - Transfer of orphan designation - Commission Decision (2018)9016 of Tue, 18 Dec 2018 European Medicines Agency (EMA) procedure number: EMA/OD/0000002753

Europe -DG Health and Food Safety

18-12-2018

Consultation: Review of Therapeutic Goods Order 54 - Standards for Disinfectants; and associated guidance

TGA is seeking comments on the expansion and amendment of TGO 54. Closing date: 12 February 2019

Therapeutic Goods Administration - Australia

17-12-2018

Orphan designation: Nanoliposomal irinotecan, Treatment of pancreatic cancer, 09/12/2011, Positive

Referral: Fosfomycin-containing medicinal products, fosfomycin calcium, fosfomycin disodium, fosfomycin sodium, fosfomycin trometamol, Article 31 referrals, Procedure started, 13/12/2018

Europe - EMA - European Medicines Agency

14-12-2018

Vectobac 12 AS

Primær information

Dokumenter

Lokation

Andre oplysninger

Status

Produktresumé: dosering, interaktioner, bivirkninger

Vectobac 12 AS Flydende middel - dansk - Produktets egenskaber